Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-17 Sale | 2024-09-17 6:20 pm | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 13,500 | $48.28 | $651,766 | 38,627 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 6:31 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $49.1 | $245,509 | 11,349 (Direct) | View |
| 2024-08-20 Purchase | 2024-08-22 4:03 pm | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 1 | $46.41 | $46 | 16,540,583 (Indirect) | View |
| 2024-07-15 Sale | 2024-07-16 6:00 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $45.53 | $1,803,143 | 164,381 (Direct) | View |
| 2024-07-09 Sale | 2024-07-09 5:15 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 453,960 | $38.21 | $17,346,919 | 723,246 (Indirect) | View |
| 2024-06-12 Sale | 2024-06-14 6:01 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 26,940 | $35.27 | $950,174 | 802,022 (Indirect) | View |
| 2024-06-07 Sale | 2024-06-07 6:36 pm | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 8,500 | $32.99 | $280,400 | 33,195 (Direct) | View |
| 2024-05-23 Sale | 2024-05-23 4:10 pm | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 2,575 | $34.99 | $90,105 | 44,183 (Direct) | View |
| 2024-03-14 Sale | 2024-03-15 7:23 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 127,543 | $40.25 | $5,133,263 | 806,697 (Indirect) | View |
| 2024-03-11 Sale | 2024-03-13 7:53 pm | Kymera Therapeutics Inc. | KYMR | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 353,357 | $42.2 | $14,912,376 | 5,504,905 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-13 7:52 pm | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 353,357 | $42.2 | $14,912,376 | 828,830 (Indirect) | View |
| 2024-03-04 Sale | 2024-03-04 6:21 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 3,344 | $41.86 | $139,967 | 241,990 (Direct) | View |
| 2024-03-04 Sale | 2024-03-04 6:12 pm | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 3,934 | $41.86 | $164,664 | 329,851 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 4:34 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $45 | $18,000 | 137,192 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 6:46 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $39.05 | $195,258 | 37,083 (Direct) | View |
| 2024-02-09 Sale | 2024-02-09 7:47 pm | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $35.5 | $1,638,071 | 137,592 (Direct) | View |
| 2024-01-23 Sale | 2024-01-23 7:37 pm | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $30.05 | $300,470 | 21,349 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 5:15 pm | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 3,295 | $22.58 | $74,416 | 34,205 (Direct) | View |
| 2023-11-02 Purchase | 2023-11-06 6:07 pm | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 414,105 | $12.8 | $5,301,325 | 378,822 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 8,500 | $29.55 | 38,627 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A 2030-09-03 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 13,500 | $0 | 38,627 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-17 6:20 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 5,000 | $14.18 | 38,627 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:31 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $10.34 | 11,349 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:31 pm | N/A 2030-07-28 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $0 | 11,349 (Direct) | View |
| 2024-07-15 Exercise | 2024-07-16 6:00 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $0 | 164,381 (Direct) | View |
| 2024-07-15 Exercise | 2024-07-16 6:00 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 39,600 | $2.08 | 164,381 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-01 4:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 18,773 | $5.33 | 938,415 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-01 4:30 pm | N/A 2030-05-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 18,773 | $0 | 938,415 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-28 5:05 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks and Footnotes | 16,000 | $0 | 6,134,102 (Indirect) | View |
| 2024-06-27 Exercise | 2024-06-28 08:30 am | N/A 2029-08-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 25,000 | $0 | 273,453 (Direct) | View |
| 2024-06-27 Exercise | 2024-06-28 08:30 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 25,000 | $2.08 | 273,453 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Esposito Pamela Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Booth Bruce Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Hrustanovic Gorjan Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | MARAGANORE JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Morgan Leigh Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Sandor Victor Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 08:30 am | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 14,413 | $0 | 1,136,745 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 08:30 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 14,413 | $2.08 | 1,136,745 (Direct) | View |
| 2024-06-07 Exercise | 2024-06-07 6:36 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 8,500 | $0 | 33,195 (Direct) | View |
| 2024-06-07 Exercise | 2024-06-07 6:36 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Horobin Joanna Director | 8,500 | $2.08 | 33,195 (Direct) | View |
| 2024-03-28 Option Award | 2024-04-01 08:56 am | N/A 2034-03-27 | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 64,000 | $0 | 64,000 (Indirect) | View |
Ownership | 2024-04-01 08:53 am | N/A N/A | Kymera Therapeutics Inc. | KYMR | BAKER BROS. ADVISORS LP Director | 0 | $0 | 13,946,423 (Indirect) | View |
| 2024-03-01 Option Award | 2024-03-04 6:21 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 170,625 | $0 | 241,990 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:16 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Chadwick Jeremy G Chief Operating Officer | 93,973 | $0 | 127,306 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:15 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Chiniara Ellen Chief Legal Officer | 152,286 | $0 | 186,491 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:12 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 530,000 | $0 | 530,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 6:12 pm | N/A 2034-02-28 | Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer | 218,750 | $0 | 329,851 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $0 | 137,192 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:34 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 400 | $2.08 | 137,192 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-21 6:46 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $10.34 | 37,083 (Direct) | View |
| 2024-02-20 Exercise | 2024-02-21 6:46 pm | N/A 2030-07-28 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 5,000 | $0 | 37,083 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $0 | 137,592 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-09 7:47 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Gollob Jared Chief Medical Officer | 46,137 | $2.08 | 137,592 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-23 7:37 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $10.34 | 21,349 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-23 7:37 pm | N/A 2030-07-28 | Kymera Therapeutics Inc. | KYMR | Albers Jeffrey W. Director | 10,000 | $0 | 21,349 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 5:43 pm | N/A 2029-11-13 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 9,000 | $0 | 1,135,542 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-02 5:43 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 9,000 | $2.08 | 1,135,542 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 6:00 pm | N/A 2029-05-22 | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 20,000 | $0 | 1,135,542 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 6:00 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Mainolfi Nello Chief Executive Officer | 20,000 | $2.08 | 1,135,542 (Direct) | View |